,i #aaeth ,,congress #b;d ,session ,h4 ,r4 #fgcc ,,in ,,the ,,house ,,of ,,representatives ,september #g1 #bjah,mr4 ,carter of ,georgia 7for himself1 ,mr4 ,paulsen1 ,mr4 ,doggett1 ,mr4 ,welch1 ,mrs4 ,mc,morris ,rodgers1 ,ms4 ,eshoo1 ,mr4 ,griffith1 ,mrs4 ,dingell1 ,mr4 ,burgess1 and ,mr4 ,gene ,green of ,texas7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend title ,,xxvii of the ,public ,health ,service ,act and title ,,xviii of the ,social ,security ,act to prohibit group health plans1 health insurance issuers1 prescription drug plan sponsors1 and ,medicare ,advantage organizations from limiting certain information on drug prices4 #a4 ,short title ,this ,act may be cited as the ,know the ,cost ,act of #bjah4 #b4 ,prohibition on limiting certain information on drug prices 7a7 ,in general 7#a7 ,group health plans and health insurance issuers ,subpart ,,ii of part ,a of title ,,xxvii of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;gg-#aa et seq47 is amended by adding at the end the following3 #bgbi4 ,information on prescription drugs 7a7 ,in general ,a group health plan or a health insurance issuer offering group or individual health insurance coverage shall-- 7#a7 not restrict1 directly or indirectly1 any pharmacy that dispenses a prescription drug to an enrollee in the plan or coverage from informing 7or penalize such pharmacy for informing7 an enrollee of any differential between the enrollee's out-of-pocket cost under the plan or coverage with respect to acquisition of the drug and the amount an individual would pay for acquisition of the drug without using any health plan or health insurance coverage2 and 7#b7 ensure that any entity that provides pharmacy benefits management services under a contract with any such health plan or health insurance coverage does not1 with respect to such plan or coverage1 restrict1 directly or indirectly1 a pharmacy that dispenses a prescription drug from informing 7or penalize such pharmacy for informing7 an enrollee of any differential between the enrollee's out-of-pocket cost under the plan or coverage with respect to acquisition of the drug and the amount an individual would pay for acquisition of the drug without using any health plan or health insurance coverage4 7b7 ,definition ,for purposes of this section1 the term out-of-pocket cost1 with respect to acquisition of a drug1 means the amount to be paid by the enrollee under the plan or coverage1 including any cost-sharing 7including any deductible1 copayment1 or coinsurance7 and1 as determined by the ,secretary1 any other expenditure4 4 7#b7 ,prescription drug plan sponsors and ,medicare ,advantage organizations ,section #ahfj;,d-#d of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#ajd7 is amended by adding at the end the following new subsection3 7m7 ,prohibition on limiting certain information on drug prices ,a ,,pdp sponsor and a ,medicare ,advantage organization shall ensure that each prescription drug plan or ,,ma-,,pd plan offered by the sponsor or organization does not restrict a pharmacy that dispenses a prescription drug or biological from informing1 nor penalize such pharmacy for informing1 an enrollee in such plan of any differential between the negotiated price of1 or copayment or coinsurance for1 the drug or biological to the enrollee under the plan and a lower price the individual would pay for the drug or biological if the enrollee obtained the drug without using any health insurance coverage4 4 7#c7 ,effective date ,the amendments made by this subsection shall apply with respect to plan years beginning on or after ,january #a1 #bjbj4 7b7 ,medicare beneficiary notice requirements 7#a7 ,annual notice requirement ,section #ahjd7;c7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acie;b-#b7;c77 is amended-- 7,a7 in paragraph 7#c71 by striking and at the end2 7,b7 in paragraph 7#d71 by striking the period at the end and inserting 2 and2 and 7,c7 by adding at the end the following new paragraph3 7#e7 with respect to a notice provided on or after ,january #a1 #bjbj1 and an individual enrolled in a prescription drug plan under part ,d or an ,,ma-,,pd plan under part ,c1 information on the potential effects purchasing a drug without using benefits provided under such prescription drug plan or ,,ma-,,pd plan may have on such individual's deductible and future cost-sharing obligations under such prescription drug plan or ,,ma-,,pd plan4 4 7#b7 ,,ma organization and ,,pdp sponsor disclosures 7,a7 ,in general ,section #aheb7;c77#a7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#bb7;c77#a77 is amended by adding at the end the following new subparagraph3 7,j7 ,drug purchasing information ,with respect to an enrollee in an ,,ma-,,pd plan1 information in a form and manner specified by the ,secretary on the potential effects purchasing a drug without using benefits provided under such plan may have on such individual's deductible and future cost-sharing obligations under such plan4 4 7,b7 ,effective date ,the amendment made by this paragraph shall apply with respect to disclosures made on or after ,january #a1 #bjbj4